title: Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
abstract: BACKGROUND
  Lymphangioleiomyomatosis (LAM) is a rare lung disease characterised by progressive airflow obstruction. No effective medical treatment is available but therapy with sirolimus has shown some promise. The aim of this observational study was to evaluate sirolimus in progressive LAM.
  
  
  METHODS
  Sirolimus (trough level 5 - 10 ng/ml) was administered to ten female patients (42.4 ± 11.9 years) with documented progression. Serial pulmonary function tests and six-minute-walk-distance (6-MWD) assessments were performed.
  
  
  RESULTS
  The mean loss of FEV1 was -2.30 ± 0.52 ml/day before therapy and a significant mean gain of FEV1 of 1.19 ± 0.26 ml/day was detected during treatment (p = 0.001). Mean FEV1 and FVC at baseline were 1.12 ± 0.15 l (36.1 ± 4.5%pred.) and 2.47 ± 0.25 l (69.2 ± 6.5%pred.), respectively. At three and six months during follow-up a significant increase of FEV1 and FVC was demonstrated (3 months ΔFEV1: 220 ± 82 ml, p = 0.024; 6 months ΔFEV1: 345 ± 58 ml, p = 0.001); (3 months ΔFVC: 360 ± 141 ml, p = 0.031; 6 months ΔFVC: 488 ± 138 ml, p = 0.006). Sirolimus was discontinued in 3 patients because of serious recurrent lower respiratory tract infection or sirolimus-induced pneumonitis. No deaths and no pneumothoraces occurred during therapy.
  
  
  CONCLUSIONS
  Our data suggest that sirolimus might be considered as a therapeutic option in rapidly declining LAM patients. However, sirolimus administration may be associated with severe respiratory adverse events requiring treatment cessation in some patients. Moreover, discontinuation of sirolimus is mandatory prior to lung transplantation.
authors: Department of Int, Medicine I, Division of Pulmonary Diseases, Klinikum Grosshadern, Ludwig-Maximilians University, Comprehensive Pneumology Center, Marchioninistrasse 15, 81377 Munich, Germany. claus.neurohr@med.uni-muenchen.de
authors: Claus
authors: C
authors: Neurohr
authors: Anna L
authors: AL
authors: Hoffmann
authors: Patrick
authors: P
authors: Huppmann
authors: Vivian A
authors: VA
authors: Herrera
authors: Franziska
authors: F
authors: Ihle
authors: Stefan
authors: S
authors: Leuschner
authors: Werner
authors: W
authors: von Wulffen
authors: Tobias
authors: T
authors: Meis
authors: Carlos
authors: C
authors: Baezner
authors: Hanno
authors: H
authors: Leuchte
authors: Rainer
authors: R
authors: Baumgartner
authors: Gregor
authors: G
authors: Zimmermann
authors: Juergen
authors: J
authors: Behr
references: N Engl J Med. 2008 Jan 10;358(2):200-3
references: 18184971
references: Chest. 2008 Feb;133(2):507-16
references: 18252917
references: Chest. 2004 Dec;126(6):1867-74
references: 15596686
references: N Engl J Med. 2008 Jan 10;358(2):190-2
references: 18184966
references: N Engl J Med. 2011 Apr 28;364(17):1595-606
references: 21410393
references: Arch Neurol. 2000 May;57(5):662-5
references: 10815131
references: Lymphat Res Biol. 2010 Mar;8(1):9-19
references: 20235883
references: Chest. 2008 Feb;133(2):448-54
references: 18071009
references: Eur Respir J Suppl. 1993 Mar;16:5-40
references: 8499054
references: Eur J Intern Med. 2008 Jul;19(5):319-24
references: 18549932
references: N Engl J Med. 2006 Sep 28;355(13):1345-56
references: 17005952
references: Biochem Soc Trans. 2009 Feb;37(Pt 1):259-64
references: 19143643
references: Am J Respir Crit Care Med. 2003 Apr 1;167(7):976-82
references: 12411287
references: Med Sci Sports. 1975 Winter;7(4):312-5
references: 14295
references: J Heart Lung Transplant. 2009 Jan;28(1):1-7
references: 19134523
references: Cancer Control. 2006 Oct;13(4):276-85
references: 17075565
references: Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
references: 12091180
references: J Heart Lung Transplant. 2007 Dec;26(12):1293-9
references: 18096481
references: Respir Med. 2010 Jul;104 Suppl 1:S33-41
references: 20451364
references: Ann Intern Med. 2007 May 1;146(9):687-8
references: 17470843
references: Eur Respir J. 2010 Jan;35(1):14-26
references: 20044458
references: Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11
references: 16210669
references: Chest. 2009 Dec;136(6):1596-1603
references: 19447921
references: N Engl J Med. 2008 Jan 10;358(2):140-51
references: 18184959